Recent Finacing
Recent Raise
AGTC is a clinical-stage biotechnology company developing AAV-based gene therapies for rare retinal and genetic disorders, operating proprietary non-pathogenic AAV delivery and production infrastructure and partnering for development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors